Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Statin (Protein)
57%
Malignant Neoplasm
43%
Diseases
41%
Infection
40%
Fibrosing Alveolitis
40%
Monotherapy
37%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
36%
Adverse Outcome
33%
Cerebrovascular Accident
32%
Acute Coronary Syndrome
31%
Chronic Kidney Failure
31%
Nonhodgkin Lymphoma
31%
Acute Heart Infarction
30%
Liver Cell Carcinoma
30%
Non Small Cell Lung Cancer
30%
Ovary Cancer
30%
Antiplatelet
27%
Brain Ischemia
25%
Atrial Fibrillation
25%
Protein Tyrosine Kinase Inhibitor
23%
Clopidogrel
23%
Ovary Carcinoma
22%
Biological Marker
21%
Congestive Heart Failure
21%
Acetylsalicylic Acid
21%
Breast Cancer
21%
Sleep Disordered Breathing
20%
Drug Resistance
20%
Nintedanib
20%
Ticagrelor
20%
Metformin
20%
Non Insulin Dependent Diabetes Mellitus
20%
Syndrome
20%
Standardized Incidence Ratio
17%
End Stage Renal Disease
17%
Chemotherapy
16%
Pitavastatin
16%
Neoplasm
15%
Hemodialysis
15%
Brain Hemorrhage
15%
Warfarin
15%
Epidermal Growth Factor Receptor
14%
Immune Checkpoint Inhibitor
13%
Adverse Event
13%
All Cause Mortality
13%
Comorbidity
12%
Cardiotoxicity
12%
Cardiovascular Disease
12%
Observational Study
11%
Medicine and Dentistry
Hazard Ratio
54%
Apoplexy
41%
Cohort Analysis
40%
Peritoneal Dialysis
32%
Non-Hodgkin Lymphoma
31%
Hepatocellular Carcinoma
30%
Standardized Incidence Ratio
29%
Brain Ischemia
24%
Malignant Neoplasm
22%
Biological Marker
21%
Diseases
21%
Pre-Eclampsia
20%
Recurrent Pregnancy Loss
20%
Systemic Lupus Erythematosus
20%
Glycon
20%
Lifespan
20%
Ovarian Cancer
20%
Inflammatory Bowel Disease
20%
Maturity Onset Diabetes of the Young
20%
Crohn's Disease
17%
Ulcerative Colitis
17%
Hemodialysis
15%
Cancer
15%
Retrospective Cohort Study
15%
Warfarin
15%
Immune Checkpoint Inhibitor
14%
End Stage Renal Disease
14%
Logistic Regression Analysis
14%
Thymic Carcinoma
14%
Thymus Cancer
14%
Congestive Heart Failure
14%
Cancer Risk
13%
Adverse Outcome
13%
Antiplatelet
12%
Neoplasm
12%
Krukenberg Tumor
12%
Retrospective Study
12%
Cytokine
12%
Patient with Type 2 Diabetes
12%
Hematologic Malignancy
11%
Odds Ratio
11%
Proportional Hazards Model
11%
Upregulation
11%
Monotherapy
11%
Antithrombotic
11%
Chronic Kidney Disease
11%
DNA Polymorphism
11%
Patient with Epilepsy
11%
Breast Cancer
10%
Kidney Function
10%
Keyphrases
National Cohort Study
62%
Taiwan
47%
Population-based Study
40%
Bidirectional Association
30%
Non-Hodgkin Lymphoma
30%
Statins
29%
Adjusted Hazard Ratio
23%
Major Adverse Cardiovascular Events
23%
Taiwanese
23%
Asia
22%
Clinical Outcomes
21%
Peritoneal Dialysis
21%
Primary Sjgren's Syndrome
20%
Niacin
20%
Non-psychotic Disorders
20%
Capture-recapture Models
20%
Statin Use
20%
Patients with Breast Cancer
20%
All-cause Mortality
17%
Confidence Interval
17%
Atrial Fibrillation
16%
Pitavastatin
16%
Percutaneous Coronary Intervention
16%
Schizophrenic Patients
15%
Capture-recapture
15%
Peritoneal Dialysis Patients
15%
Schizophrenia
14%
Footnotes
14%
Hemorrhagic Stroke
13%
Cardiovascular Outcomes
13%
Cancer Risk
12%
Vulnerability Indicators
12%
Safety Outcomes
12%
Cause of Death
12%
National Health Insurance Research Database (NHIRD)
12%
Familial Aggregation
11%
Acute Coronary Syndrome
11%
Low Risk
11%
Adverse Events
11%
Maintenance Hemodialysis Patients
11%
Cardiotoxicity
10%
Aspirin
10%
Standardized Incidence Ratio
10%
Health Information Sources
10%
Antiplatelet Therapy
10%
Acute Kidney Injury
10%
Infrared Photos
10%
Photoenergy
10%
Adolescent Perspectives
10%
Outer Mitochondrial Membrane
10%
